ClinicalTrials.Veeva

Menu

Iron Supplementation Among Low-Income Postpartum Women

Centers for Disease Control and Prevention (CDC) logo

Centers for Disease Control and Prevention (CDC)

Status and phase

Completed
Phase 3

Conditions

Anemia

Treatments

Behavioral: Selective anemia screening and treatment
Behavioral: Daily iron supplements of 65 mg a day for 3 months
Behavioral: Universal anemia screening and treatment

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT00207610
CDC-NCCDPHP-TS-0780

Details and patient eligibility

About

Anemia is common among low-income women after they have given birth. Anemia, or low hemoglobin in the blood cells, is usually caused by not having enough iron. Blood cells usually carry oxygen to other parts of the body. Without enough hemoglobin, the ability of blood cells to carry oxygen is decreased. Memory and work may be impaired. The purpose of this study is to evaluate three methods of giving iron to prevent anemia among low-income women after they have given birth.

Full description

Currently the Centers for Disease Control and Prevention recommendations to prevent iron deficiency advocate selective screening and treatment of anemia at about 6 weeks postpartum. However, among some groups, such as low income women, data suggest that anemia and iron deficiency are common. This study aims to evaluate the effectiveness of three stategies to prevent iron deficiency among low income postpartum women in Mississippi.

Comparisons: Clinics will be randomized to one of three strategies: 1)Selective anemia screening and treatment of anemic women, 2)universal anemia screening and treatment of anemic women, or 3)universal iron supplementation of 65 mg a day for three months.

Enrollment

959 patients

Sex

Female

Ages

13+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • postpartum girls and women, 2-6 weeks after birth
  • age 13 years or more
  • WIC certified

Exclusion criteria

  • sickle cell anemia
  • Hemoglobin < 7 g/dL

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems